about
In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gammaAllergenicity resulting from functional mimicry of a Toll-like receptor complex proteinIdentification of IFRD1 as a modifier gene for cystic fibrosis lung diseaseNegative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105Evaluating the value proposition for improving vaccine thermostability to increase vaccine impact in low and middle-income countriesC5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonismTuberculosis vaccines: barriers and prospects on the quest for a transformative toolTherapeutic enhancement of protective immunity during experimental leishmaniasisCoinfection with HIV and tropical infectious diseases. I. Protozoal pathogens.Coinfection with HIV and tropical infectious diseases. II. Helminthic, fungal, bacterial, and viral pathogens.Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10.ATF3 is a novel regulator of mouse neutrophil migrationGetting to the core of the gut microbiome.Measles: immunosuppression, interleukin-12, and complement receptors.Receptor mediated subversion of macrophage cytokine production by intracellular pathogens.Mapping of specific and promiscuous HLA-DR-restricted T-cell epitopes on the Plasmodium falciparum 27-kilodalton sexual stage-specific antigen.Tracking antigen-specific CD4+ T cells throughout the course of chronic Leishmania major infection in resistant mice.Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitisComplement and IL-12: yin and yang.Cnr2 deficiency confers resistance to inflammation-induced preterm birth in mice.An adenoviral vector for probing promoter activity in primary immune cellsContributions of the three CYP1 monooxygenases to pro-inflammatory and inflammation-resolution lipid mediator pathwaysThe germless theory of allergic disease: revisiting the hygiene hypothesis.Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cellsLipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis.Immunological barriers (opportunities?) to the use of bioengineered tissue: taking note of the innate immune system.Shifting hierarchies of interleukin-10-producing T cell populations in the central nervous system during acute and persistent viral encephalomyelitis.Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization.Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection.Distinct Tlr4-expressing cell compartments control neutrophilic and eosinophilic airway inflammationThe anaphylatoxins bridge innate and adaptive immune responses in allergic asthma.Non-canonical alternatives: what a macrophage is 4Can immunological principles and cross-disciplinary science illuminate the path to vaccines for HIV and other global health challenges?Emergence of distinct multiarmed immunoregulatory antigen-presenting cells during persistent viral infectionIL-10 regulates Il12b expression via histone deacetylation: implications for intestinal macrophage homeostasis.Cystic fibrosis and lipoxins.Proapoptotic Bcl-2 family member Bim promotes persistent infection and limits protective immunityRegulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105.T-cell responses to infected autologous monocytes in patients with cutaneous and mucocutaneous leishmaniasisInterferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever.
P50
Q24599396-D3FEB63B-A8DB-4996-B90C-DE172FF1D5B3Q24617663-E26FEAA1-40BF-4DE8-A596-5DD1845EC97DQ24621702-78D18631-846D-4302-BCFB-BF0FC52D371AQ24671928-C9C7C600-3830-4688-B8DB-11BBD9D092D2Q26823396-449745E9-8EF1-49AF-A888-EFD6667AEFCCQ28211612-3394E383-5667-4F11-A265-C36D66BB44A0Q28390218-849BF60B-4192-4D29-99E0-147787B569D4Q28476803-058BBBA2-D643-4E0A-90A8-7551274335C3Q30364997-84A58FF3-9CEE-4168-95F7-01F175D0A1F3Q30364999-4B0EEC16-2861-4418-BB52-ADE934186B4BQ30438825-3DBD6B38-7543-44D7-8EAE-D131379B4F29Q30574792-A325FD49-50C3-4137-8C46-7F08B41FC83EQ33427783-37E3A4BF-3587-4BED-AD67-07E98B9C7FE7Q33683348-21CB74AA-494C-43CE-935E-AAB0325B3F65Q33711413-52B3E4FE-DC0D-4336-8043-F8E01950FEFCQ33757364-6D51AA04-E967-4AC7-8035-8961BEC97631Q33861565-FC88EFBA-A591-4F45-8AB5-3D55F80A853CQ33966409-D7817BE7-1D32-4C65-9C0A-9646B69D4AFAQ34184411-FF469C04-31C7-48D8-BD7A-49A1B485B1A6Q34185758-CBE89157-7E46-4B52-A9CE-33BA5802D28CQ34244730-174CDBE0-9EAD-4B90-BF92-8761A1F44359Q34364936-B372070A-4AB6-47A1-8DDC-7192B49D66C8Q34572144-250B2243-E348-414D-A9BB-2C5C72152712Q34609504-0A04C3D6-9E94-4E67-8CDE-8A2DD49A4B6BQ34640072-0D947291-70DF-4261-AD5E-E907DF8E652EQ34704462-50697B6D-CA00-4689-863E-E74CF9C904A6Q35077519-D1FDA64A-64E5-405C-9BCC-7644D44BB2B2Q35091226-3F5EE76E-40A1-4A34-BEE2-6A9F39D596E2Q35623712-ED546FBC-2C53-471E-8783-A7D405D31791Q35680457-41411CD2-6889-4640-BE69-2ED618D190D2Q35781827-07F21B10-F663-4E5B-B780-5BD8CA8FE932Q35825965-99D17430-6230-411E-9266-EC0E4B0FE7A0Q35923859-0B93F925-91EE-4A17-BC3C-8672C6CA5876Q35987045-D52D8AC5-1045-4DD7-8739-B516D6702739Q36140037-CE3C7079-FBA9-41B9-A639-97E4137120DAQ36175653-0849EDE2-A91D-4446-87C4-80BDFC82F833Q36483578-DE55BB07-D07C-4CD1-B9A3-BFFC76E73725Q36807091-BD7C7C06-4A13-458C-A49D-5DA2F691C7BDQ36928976-38B04F2D-D8F2-46F0-A939-8ED5BDC8DEDEQ36936330-C9D92C86-3FCD-403A-8F2C-6333A3123E16
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Christopher L Karp
@ast
Christopher L Karp
@en
Christopher L Karp
@es
Christopher L Karp
@sl
type
label
Christopher L Karp
@ast
Christopher L Karp
@en
Christopher L Karp
@es
Christopher L Karp
@sl
prefLabel
Christopher L Karp
@ast
Christopher L Karp
@en
Christopher L Karp
@es
Christopher L Karp
@sl
P106
P21
P31
P496
0000-0002-0832-2659